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In this study, we investigated whether gongjin-dan improves functional recovery and has neuroprotective eﬀects on reducing
the infarct volume after transient middle cerebral artery occlusion (MCAo). Infarct volume was measured using TTC staining
and glucose utilization by F-18 FDG PET. Functional improvement was evaluated with the Rota-rod, treadmill, Garcia score
test, and adhesive removal test. At 14 days after MCAo, neuronal cell survival, astrocytes expansion, and apoptosis were assessed
by immunohistoﬂuorescence staining in the peri-infarct region. Also, the expression of neurotrophic factors and inﬂammatory
cytokines such as VEGF, BDNF, Cox-2, TNF-α,I L - 1 β,a n dI L - 1 α was measured in ischemic hemisphere regions. The gongjin-dan-
treated group showed both reduced infarct volume and increased glucose utilization. Behavior tests demonstrated a signiﬁcant
improvement compared to the control. Also in the gongjin-dan treated group, NeuN-positive cells were increased and number of
astrocytes, microglia, and apoptotic cells was signiﬁcantly decreased compared with the control group in the ischemic peri-infarct
area. Furthermore, the expression of VEGF and BDNF was increased and level of Cox-2, TNF-α,I L - 1 β,a n dI L - 1 α was decreased.
These results suggest that gongjin-dan may improve functional outcome through the rapid restoration of metabolism and can be
considered as a potential neuroprotective agent.
1.Introduction
Ischemic stroke is a second leading cause of death in indus-
trialized countries and arguably the most important cause of
acquired disability [1, 2]. The initial pathophysiology due to
a reduction or complete blockade of regional cerebral blood
ﬂow (rCBF) results in deﬁcient glucose and oxygen supply to
the aﬀected region [3, 4]. Ischemic stroke can be separated
into three serial phases following injury: acute (minutes to
hours, metabolic stress and excitotoxicity), subacute (hours
to days, inﬂammation and apoptosis), and chronic (days to
months, repair and regeneration) [5–7].
In acute stroke, the primary brain insult is largely
attributed to interruption of CBF and breakdown of the
blood brain barrier (BBB). The reduction of rCBF causes
cerebral infarction such as middle cerebral artery occlusion
(MCAo). rCBF of ischemic core was decreased 5–20%
[8]. Also with rCBF recovery immediately after stroke,
damaged cells in the ischemic penumbra can be rescued.
Changes in rCBF and metabolism are commonly associated
with brain disorders, such as traumatic brain injury and
ischemic stroke [9, 10]. Also, BBB disruption after MCAo
has been implicated in hemorrhagic transformation [11].
In the normal state, glucose is the predominant substrate2 Evidence-Based Complementary and Alternative Medicine
for energy metabolism in the brain and has a tightly
controlled relationship with rCBF. The glucose analogue F-
18FDG (2-[F-18]-ﬂuoro-2-deoxy-D-glucose) is anindicator
of utilization and the degree of neuronal activity in the brain
[12]. Furthermore, positron emission tomography (PET)
detection of F-18 FDG uptake is therefore valuable in the
study of stroke, brain injury, and speciﬁc function of living
animals.
In recent studies, a consideration has been given to the
individual active compound alone as well as in combination
with other herbs [2, 13, 14]. Numerous studies have
sought novel neuroprotective substances and the beneﬁcial
eﬀects of herbal medicines against brain ischemia have
often been reported. This is related by the inhibition of
inﬂammatory cytokines and microglia activation in brain
ischemia. In traditional oriental medicine, many herbal
drugs and prescriptions have in fact been used clinically
for the treatment of ischemic stroke and vascular dementia.
Gongjin-dan is a multiherbal formula available in Korea
and China and is known as an antifatigue and antiaging
agent. It has also been used as alternative medicine for
the treatment of various neurodegenerative disorders. Moon
et al. reported that learning and memory were enhanced
following administration of gongjin-dan in the stress rat
model [15]. However, experimental evidence clarifying the
mechanism of gongjin-dan is limited at best.
Herein,weevaluatedtheeﬀectsofgongjin-danoninfarct
volume and functional recovery, as well as on glucose
metabolism, apoptosis and survival of living cells, and
change of inﬂammatory cytokines and growth factors in an
ischemic stroke rat model.
2. Methods
2.1. Preparation and Administration of Gongjin-dan. For this
study, gongjin-dan was prepared as a mixture of Moschus
moschiferus (175mg), Corni Fructus (1.5g), Angelica gigantis
radix (1.5g), and Cervi Parvum Cornu (1.5g). Gongjin-dan
was extracted using reﬂux extraction equipment in hot water
for an hour and concentrated using a rotary evaporator
before lyophilization. Gongjin-dan was treated with twice
(40mg/kg) per day for 14 days after the stroke.
2.2. Cerebral Ischemic Model. The experimental protocol
used in this study was designed in compliance with the
guidelines established by the Institutional Animal Care and
Use Committee of Catholic University Medical School. Tran-
sient MCAo was modeled as described previously [16–18],
with slight modiﬁcation. Adult male Sprague-Dawley rats
(270–300g) were initially anesthetized with 5% isoﬂurane
in 70% nitrous oxide and 30% oxygen using an induction
chamber and maintained by a mixture of 2% isoﬂurane
under temperature controlled conditions (37 ± 0.1◦C) using
a rectal thermometer and heating pad (Harvard Apparatus
Inc., Holliston, Massachusetts, USA). The right common
carotid artery (CCA), external carotid artery (ECA), and
internal carotid artery (ICA) were exposed through a ventral
midline incision. A 4–0 monoﬁlament nylon suture with a
rounded tip was inserted into the CCA lumen and gently
advanced into the ICA until it blocked the bifurcating origin
of the MCA. Cortical blood ﬂow was measured continuously
via laser doppler (Transonic system Inc., Ithaca, NY, USA)
with a photodetector probe that was stereotaxically placed
through a burr hole in the skull overlying frontoparietal
cortex (1.3mm posterior, 2.8mm lateral to the bregma).
Ninety minutes later, animals were reanesthetized and then
reperfused by withdrawal of the suture until the tip cleared
the ECA lumen. rCBF was expressed as a percentage of pre-
ischemic baseline values. MCAo animals were only included
in the present study if occlusion caused a decrease in rCBF to
less than 30% of the original blood ﬂow.
2.3. Behavior Evaluation. Following MCAo, animals were
randomly divided into two experimental groups: a controls
receivedgastricgavagewithdistilledwater(n = 7).Theother
group received gongjin-dan (n = 7). Behavior was assessed
with the Garcia score test, adhesive removal, Rota-rod, and
treadmill test at 1, 3, 7, 10, and 14 days following MCAo by
an investigator blinded to the experimental groups. Subjects
were pretrained on all tests for 3 days pre-MCAo, with only
exception being the Garcia test.
2.3.1. Garcia Score Test. Motor behavior index was scored
blind to rat groupings by the Garcia test [19, 20]. Brieﬂy,
subjects were evaluated on six criteria for a possible total
score ranging from 3 to 18, with a higher score indicating
better performance. Motor performance was evaluated on
spontaneous activity, symmetry of movements, symmetry of
forelimbs, and climbing the wall of wire cage, and sensory
function was measured (while reaction to touch on and
response to vibrissae touch).
2.3.2. Adhesive Removal Test. For adhesive removal tests,
squaredotsofadhesive-backedpaper(113.1mm2)wereused
as bilateral tactile stimuli on the radial wrist of both distal
forelimbs [21] .T h et i m er e q u i r e dt or e m o v eb o t hs t i m u l i
from each limb was recorded in ﬁve trials/day for 3 days.
All animals could remove the dot within 10sec at the end
of training. So, the rats were familiarized with the testing
environment. Resultant data are presented as the mean time
required to removal the left dot.
2.3.3. Rota-Rod Test. Subjects were pretrained on the Rota-
rod motor test three times/day for 3 days pre-MCAo. The
Rota-rod cylinder (Cytec Korea Inc, Seoul, Korea) was
accelerated from 4 to 40rpm within 5 minutes. Only animals
capable of remaining on the Rota-rod cylinder for more than
160 seconds were included in the study and the cutoﬀ time
was 300 seconds. Data are presented as the mean duration
from three trials.
2.3.4. Treadmill Test. Subjects were trained on a motor-
driven treadmill (Panlab, Barcelona, Spain) for 20min/day,
3days/week at a speed of 20m/min prior to MCAo induc-
tion. Rats were placed on a moving belt facing away from
the electriﬁed grid forcing them to run in the directionEvidence-Based Complementary and Alternative Medicine 3
opposite of belt movement. To avoid foot shocks (with
1.0mA (intensity)), the rats had to move forward. Only
those which learned to avoid the mild electrical shock were
included in this study. The maximum velocity at which the
rats could run on a motor-driven treadmill was recorded to
measure 3 times [22, 23].
2.4. rCBF Measurements. rCBF was measured as described
in previous literature [24]. Rats were anesthetized (0.8%
to 1.5% isoﬂurane, 30% O2, remainder N2O) and rectal
temperature was maintained at 37 ± 0.1◦C using a feedback
controlled heating system. They were then ﬁxed to a
stereotaxic apparatus with a probe placed at the level of the
dura directly overlying the small burr hole used to induce
MCAo. rCBF was measured at the time of MCAo onset and
reperfusion. Subsequent measurements were taken during
15min/day over the next 14 days. rCBF was expressed as a
percentage of preischemic baseline values. Two investigator
blinded to the experimental groups performed the rCBF
recordings.
2.5. PET Imaging. PET imaging was performed on images
taken on days 1 and 14 days after MCAo on a PET scanner
using a General Electric discovery STE (Waukesha, WI,
USA). Subjects were deprived of food for about 12∼16
hours preceding F-18 FDG injection but had access to
drinking water at all times. F-18 FDG (1.1 ± 0.04mCi) was
injected intravenously into the caudal vein, followed by a
30min uptake period, during which the subjects remained
conscious in a warm environment for optimal brain F-
18 FDG uptake, by placing the entire cage on a heating
pad. During brain scanning, anesthesia was maintained
with katamine (80mg/kg) and xyzine (10mg/kg), and body
temperature was kept at 37◦C with a heating pad on the
scanner bed. PET imaging produces 6 coronal image planes
separated by 3mm in stereotactic apparatus on pinpoint
marker.
2.6. PET Imaging Data Analysis. PET imaging data was
analyzed as per described in previous literature [10]. To
assess changes in metabolism induced by artery occlusion,
average regions of interest (ROI) in each hemisphere were
identiﬁed in images of the coronal brain sections. The
mean standard uptake value (SUV) of F-18 FDG in ROI
was calculated as the averaged nCi/cc after calibration for
both ipsilateral and contralateral insulated areas in the same
images. The radioactivity in the contralateral area was used
as a reference to normalize data obtained in the ipsilateral
area, and the diﬀerential uptake ratio (DUR) was calculated
[10]. The total DUR for each imaging was calculated by
summation of all brain imaging. Also we conﬁrm whether
infarct volume was associated with elevated DUR for one
day after MCAo (see Figure 1 in Supplementary Materials
available online at doi:10.1155/2012/682720).
2.7. Quantitative Analysis of Infarct Volume. At 14 days
after MCAo, all test subjects (n = 5, for each group)
were deeply anesthetized with 15% urethane and sacriﬁced
by decapitation. The brain was immediately removed and
sectioned into four equally spaced (2mm) coronal blocks
using a rodent brain matrix. These sections were stained
with 0.1M PBS containing 2% 2-3-5-triphenylterazolium
(TTC; Sigma, St. Louis, MO, USA) for 30min at 37◦C. The
unstained area was considered to be the infract area. The
injured area of brain slices was quantiﬁed using Meta-Morph
imagingsoftware(MolecularDevicesInc,Downingtown,PA,
USA). The total infarct volume for each slice was calculated
by summation of all brain slices.
2.8. Immunohistoﬂuorescence Staining. At 14 days after
MCAO, test subjects were sacriﬁced for histological exam-
ination. Rats were deeply anesthetized with 15% urethane
and then perfused transcardially with 0.01M PBS (pH 7.4),
followed by 4% paraformaldehyde in 0.01M PBS. The brains
were removed and post-ﬁxed for 5h. The postﬁxed tissue
was equilibrated with 30% sucrose in 0.1M phosphate
buﬀer (pH 7.2) at 4◦C. The brain tissues were embedded,
snap-frozen in liquid nitrogen, and stored at −70◦C until
use. The tissue was cut into 4μm thick coronal sections
between +0.1 and 0.86mm of the bregma from each rat
for a total of three blocks. The sections were warmed up
for 20min and washed with 0.01M PBS. Sections were
blocked in normal goat serum for 1h at room tempera-
ture. The sections were incubated at 4◦C overnight with
the following antibodies: mouse antiglial ﬁbrillary acidic
protein (GFAP; Millipore, Billerica, MA, USA), mouse anti-
neuronal nuclei antigen (NeuN; Millipore), and mouse anti-
OX-42 (Millipore). After washing, sections were incubated
in Alexa 488-conjugated goat anti-mouse IgG (Molecular
probe, Eugene, Oregon, USA) for 1h at room temperature.
After washing, the sections were counterstained with 4 ,6-
diamidino-2-phenylindole (DAPI; Sigma-Aldrich). Apopto-
siswasdetectedbytheterminaldeoxynucleotidyl-transferase
mediatedd-UTP-biotinnickend(TUNEL)assayusingtheIn
Situ Cell Death Detection Kit (Roche, Mannheim, Germany)
developed using the Cy3-conjugated streptavidin (Jackson
ImmunoResearch Laboratories, Bar Harbor, MA, USA).
After washing, the sections were counterstained with DAPI,
and then observed under both a ﬂuorescence microscope
equipped with a spot digital camera and a confocal scanning
laser microscope (LSM 510, Zeiss, Oberko, Germany). Using
Meta-Morph imaging program (Molecular Devices Inc),
ischemic penumbra was determined by optical density of
GFAP and OX-42 and counting of NeuN and TUNEL-
positive cells.
2.9.Enzyme-LinkedImmunosorbentAnalysis. 14daysfollow-
ing MCAO, rat brains were removed, and coronal sections
(200mg) from −1.0 to 1.0mm to bregma in the ischemic
hemisphere were dissected on ice and were stored at −70◦C
until use. Subsequently, each tissue sample was suspended
in an equal weight of homogenate buﬀer and homogenized.
The homogenate was centrifuged (10,000g) for 30min at
4◦C. The supernatant was collected and examined using
the enzyme-linked immunosorbent assay (ELISA) to detect
the protein levels of neurotrophic factors and inﬂammatory4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Eﬀect of gongjin-dan on functional recovery after MCAo. Behavior performances in the Garcia’s score (a), adhesive removal (b),
Rota-rod (c), and treadmill test (d) from 1 to 14 days after MCAo. Behavior tests were signiﬁcantly diﬀerent at each time point starting at 3
days after MCAo. Data are expressed as mean ± SD, ∗P<0.05.
cytokines in the ischemic rat brain. The supernatant was
further analyzed to quantify the concentration of brain-
derived neurotrophic factor (BDNF; Abnova, Jhongli, Tai-
wan), vascular endothelial growth factor (VEGF; R&D sys-
tem, Minneapolis, USA), cycloxygenase-2 (Cox-2; Immuno-
Biological Laboratories, Gunma, Japan), tumor necrosis
factor-α (TNF-α; R&D system), interleukin-1α (IL-1α;R & D
system), and interleukin-1β (IL-1β; R&D system) in strict
accordance with the manufacturer’s protocols.
2.10. Statistical Analysis. The behavior tests, cerebral
ischemic volume, and cell count of apoptotic cells for both
rat groups were subjected to one-way ANOVA with post
hoc analysis, independent T-test, or Mann-Whitney U test.
Data are presented as the mean value ± standard deviation
of mean. Probability values less than 0.05 were considered
statistically signiﬁcant.
3. Results
3.1. Behavior Test. In this study, behavior tests were per-
f o r m e db o t hp r i o rt oM C A oa sw e l la s1 ,3 ,7 ,1 0 ,a n d1 4
days after MCAo. We observed an overall mortality 25%
in this model. The animals died between 3 days and 7
days after MCAo model. Garcia score, adhesive removal,
Rota-rod, and treadmill tests were done (Figure 1). Garcia
score was 18 in the normal group. At 3 days after MCAo,
scores were signiﬁcantly higher in the gongjin-dan groupEvidence-Based Complementary and Alternative Medicine 5
compared to the control group (11.75 ± 0.5v e r s u s8 .5 ± 0.6,
P<0.05). Similarly, signiﬁcant diﬀerences between the two
groups were also noted in the 14 days (12.5 ± 0.5v e r s u s
10.75 ±0.7, P<0.05). Performance on the adhesive removal
test was also compared between both groups. Gongjin-dan-
treated group are signiﬁcantly diﬀerent 3 days after MCAo
comparedwith control group(50.6±20.5versus163.9±13.9,
P<0.05) (Figure 1(b)). Although no diﬀerence in Rota-
rod assessment was noted on day 1 after MCAo, signiﬁcant
behavior recovery was demonstrated in the gongjin-dan-
treated group at 3 days after MCAo (23.7 ± 12 versus
113.75 ± 47, P<0.05) (Figure 1(c)). The maximum speed
at which the rats could run on a motor driven treadmill
wasr ec or ded.Thr eeda ysaft erMCA o ,themaximumv elocity
on the treadmill test indicated its maximum deﬁcit. There
was no signiﬁcant diﬀerence among the groups. At 7 days
after MCAo, the gongjin-dan treated group showed a greater
functional recovery than the control (68.4±4.5v e r s u s4 6 .6±
7, P<0.05) (Figure 1(d)). Maximum velocity identiﬁed the
greatest velocity at 10 days after MCAo. At 14 days after
MCAo, maximum velocity was low compared with velocity
at 10 days. This may be due to the weight variation between
diﬀerentexperiments(datanotshown).Theseresultssuggest
that gongjin-dan can promote the restoration of motor
function in rat stroke model.
3.2. Infarct Volume and PET-CT. The neuroprotective eﬀect
of gongjin-dan was evaluated by measuring the infarct
volume at 14 days after MCAo. The brain of rats was stained
with TTC to obtain the infarct volume and was calculated
by measuring the area of infarct. Figure 2 is a photograph
typical of TTC-stained sections of treatment and control
groups. As seen in Figure 2, infarct volume of the gongjin-
dan group was signiﬁcantly decreased compared to the con-
trol(108.8±42versus185±43mm3,P<0.05)(Figure 2(d)).
PET-CT has long been demonstrated as a marker of glucose
metabolism in ischemia and infarction [25, 26]. In our
studies, PET imaging data was interpreted in terms of DUR.
With the contralateral side as baseline, the metabolic change
of transient MCAo in an ipsilateral area was calculated by
ROI value. As seen in Figure 2(a), the quantiﬁcation of the
ROI radioactivity was decreased in glucose uptake following
MCAo. From these control data, a DUR in the ischemic
region was signiﬁcantly increased compared with normal. A
DUR of gongjin-dan treatment was decreased compared to
thecontrol(11.6±3.2v ersus17.4±7.9%,P<0.05).Thisdata
suggests that protected ischemic area by gongjin-dan could
uptake glucose metabolism.
3.3. Restoration of rCBF. To investigate whether gongjin-
dan treatment improved rCBF, the rCBF was measured by
laser doppler. Baseline rCBF recorded just prior to MCAo
surgery was applied to express values as a percentage.
Following reperfusion, rCBF was maintained at 60%. 2 days
after MCAo, the gongjin-dan treatment group improved
to near-normal rCBF level. In contrast, rCBF value in the
control group for 14 days was similar to the rCBF value of
reperfusion. This suggests that gongjin-dan could potentially
halt the pathological cascade of stroke. Also, it is likely
that gongjin-dan promotes behavior recovery via rCBF and
glucosemetabolismrestoration,thereafterblockingneurosis.
3.4. Activating Astrocyte, Microglia, and Neuronal Death. We
observed the number of astrocytes, microglia, and neurons
in the peri-infarct regions at 14 days after MCAo. In gongjin-
dan group, GFAP-positive cells and OX-42-positive cells
showed signiﬁcant decrease in the optical density compared
to the control group (Figures 3(g) and 3(h)). Also NeuN-
positive cells showed higher compared to the control group
(Figure 3(i)). These results suggest that the inhibitory eﬀects
of GFAP and microglial activation may contribute to its
neuroprotective eﬀects in MCAo, thereby enabling a number
of NeuN-positive cells to survive in peri-infarct region.
3.5. Apoptotic Cell Death. We observed the number of
apoptotic cells in the peri-infarct regions at 14 days after
MCAo model. Apoptotic cells were recognized by the
identiﬁcation of DNA fragmentation using the TUNEL
method. Gongjin-dan-treated groups had reduced TUNEL-
positive cells compared to the control group (108±14 versus
148 ± 41, P<0.05) (Figure 4(e)). These results suggest that
thegongjin-dan-treatedgroupeﬀectivelypreventsexpansion
apoptotic cell death in MCAo model.
3.6. Quantitative Analysis of Neurotrophic Factors and Inﬂam-
matory Cytokines. We hypothesized that gongjin-dan may
protect an injured area following a stroke by elevating neu-
rotrophic factors and by reducing inﬂammatory cytokines.
We used the ELISA to detect protein levels of neurotrophic
factorsandinﬂammatorycytokinesintheischemicratbrain.
At 14 days after MCAo, expression of BDNF and VEGF was
signiﬁcantly high compared to the control group (Figures
5(a) and 5(b)). Also inﬂammatory cytokines such as Cox-
2, IL-1α,I L - 1 β,a n dT N F - α were reduced as compared with
control group (Figures 5(c), 5(d), 5(e),a n d5(f)). These
data suggest that an increment of neurotrophic factors and
a decrease of inﬂammatory cytokines by gongjin-dan could
protect cerebral infarction and promote behavior function
recovery.
4. Discussion
During stroke, CBF is reduced and causes a decrease of
oxygen supply to the brain and an increase of glutamate,
inﬂammatory mediators, and free radicals. As a result,
cellular necrosis and delayed cell death occur. In this study,
we examined the eﬀect of the gongjin-dan treatment on
transient MCAo model. We investigated (1) whether the
infarct volume decreases, (2) whether blood circulation and
glucose metabolism improve (laser Doppler and PET-CT
were performed for measurement), (3) whether there is
functional recovery, and (4) whether neuronal cells in peri-
infarct region can be protected from death.
We performed TTC staining in MCAo model to iden-
tify the infarct volume. The gongjin-dan-treated group
showed a more diminished infarct volume as compared6 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Eﬀect of gongjin-dan on infarct volume, glucose metabolism, and regional cerebral blood ﬂow (rCBF) after MCAo. Images shown
in the PET images and TTC-stained section of control (a) and gongjin-dan treatment group (b) at 14 days. ROI by F-18 FDG uptake
was revealed as diﬀerential uptake rations (DURs) (c). Infarct volume was then analyzed using Meta-Morph program (d). In gongjin-dan
treatment group, infarct volume was decreased compared to the control group. Also glucose uptake was increased signiﬁcantly compared
with control group. rCBF was signiﬁcantly increased compared with control group (e). These eﬀe c t sw e r eo b s e r v e df o r3 ,4 ,5 ,8 ,9 ,a n d1 2
days after MCAo. Data are expressed as mean ± SD, ∗P<0.05.
with the control group. Additional immunostaining data
demonstrated that gongjin-dan suppressed the increase of
GFAP- and OX-42-positive cells in the peripheral area
of ischemic infarct. This suggested that gongjin-dan may
protect against the infarct expansion through secondary
injury caused by activated astrocytes and microglia. Also,
DNA breakage was investigated by TUNEL staining, which
can identify apoptosis and necrosis. The gongjin-dan-
treated group demonstrated more reduced TUNEL-positive
cells as compared with control group. NeuN-positive cellsEvidence-Based Complementary and Alternative Medicine 7
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Figure 3: Quantitative analysis of immunoreactivities of GFAP, NeuN, and OX-42 at days on peri-infarct area after MCAo. Histological
analysis was shown into GFAP, NeuN, OX-42 staining at 14 days after MCAo. Quantitative immunoreactivities for groups are shown
as bar graphs on the right side of each panel. The expression of GFAP in gongjin-dan group was signiﬁcantly decreased compared with
control group. NeuN-positive cells also showed diﬀerence in the control group. There were many NeuN-positive cells in gongjin-dan group
compared to control group. The expression of OX-42 in gongjin-dan group was signiﬁcantly decreased compared with control group. In the
gongjin-dan, the number of activated microglial cells was decreased and the number of neuronal cells was increased in the peri-infarct area.
Data are expressed as mean ± SD, ∗P<0.05.
were increased compared to control group as well. These
results suggest that gongjin-dan acts as a neuroprotector by
eﬀectively preventing the expansion of astrocytes, microglia
and apoptotic neuronal death in rat MCAo model.
Also,previousstudieshavereportedthatsuddendestruc-
tion of BBB can reduce CBF level considerably in injured
brain region. In our study, after measuring CBF for 14 days,
the result was suggestive of the possibility that gongjin-dan
can improve blood circulation by restoring rCBF. To support
our hypothesis, we measured brain metabolic activity by
using F-18 FDG PET-CT. Previous reports have shown
that the increased uptake of F-18 FDG is related to the
functional restoration [10, 27]. In the normal rat, there was
nodiﬀerencebetweentheROIvaluesofthebilateralsidesbut
the value of the injured region was quite reduced. However,
in our study, the gongjin-dan-treated group demonstrated8 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Eﬀect of gongjin-dan on the number of apoptotic cells after MCAo. TUNEL staining was used to identify apoptotic cells. (a)
Apoptotic cells were identiﬁed by immunoﬂuorescence Cy3 (red). TUNEL positive cells were counted using Meta-Morph program (b, d).
TUNEL positive cells show the quantitative analysis data (e). The number of TUNEL positive cells was signiﬁcantly decreased in the drug
treated group compared to the control group. Data are expressed as mean ± SD, ∗P<0.05, Scale bars denote, 50μm.
considerable reduction of DUR compared to the control
group 14 days after MCAo. These results suggest that
gongjin-dan may improve functional recovery by increasing
rCBF, oxygen supply and glucose utilization of the brain.
After stroke, rats demonstrate disruption of sensorimo-
torabilityandcognitivefunction.Alotofearlierstudieshave
measured behavioral function by Garcia score [19], adhesive
removal [21], and Rota-rod, treadmill test [23]. These
behavioral tests in the gongjin-dan-treated group showed
signiﬁcant functional improvement in comprehensive motor
andsensorytestfrom3daysto14daysafterMCAo.Ourdata
suggests that gongjin-dan can promote the restoration of
motor function in stroke model at an early stage. Moon et al.
reported that gongjin-dan improved memory and learning
[15]. They insisted that gongjin-dan promotes secretion of
nerve growth factor resulting in blocking of apoptotic cell
death, leading to improved neuronal survival. Neurotrophic
factorssuchasNGFandBDNFhavebeenthoughtasbinding
Trks receptor [28].Theactivationofthesepathwaysregulates
neuronal survival, diﬀerentiation, and synaptic transmission
[29]. Also, it protects neuron in various circumstances such
as hypoglycemia [30] and ethanol neurotoxicity [31]. We
suggest that gongjin-dan can induce activation of neu-
rotrophic factors. Also among the components of gongjin-
dan are included the phosphatidylcholine and choline [32].
Phosphatidylcholine has been reported to have an antioxi-
dant eﬀect, improve memory, and help nourishing brain [33,
34]. Additionally, it has been shown to improve cholesterolEvidence-Based Complementary and Alternative Medicine 9
∗
Control Gongjin-dan
B
D
N
F
 
(
p
g
/
m
g
)
0
50
100
150
200
250
300
(a)
∗
Control Gongjin-dan
0
100
200
300
400
500
V
E
G
F
 
(
p
g
/
m
g
)
(b)
Control Gongjin-dan
C
o
x
-
2
 
(
p
g
/
m
g
)
0
0.5
1
1.5
2
2.5
3
3.5
∗
(c)
Control Gongjin-dan
0
10
20
30
40
50
T
N
F
-
α
(
p
g
/
m
g
)
∗
(d)
Control Gongjin-dan
0
20
40
60
80
100
120
140
I
L
-
1
β
(
p
g
/
m
g
)
∗
(e)
Control Gongjin-dan
0
20
40
60
80
I
L
-
1
α
(
p
g
/
m
g
) ∗
(f)
Figure 5: Expression of growth factors and inﬂammatory cytokines in the ischemic rat brain. BDNF, VEGF, Cox-2, TNF-α,I L - 1 β,a n dI L - 1 α
were detected by ELISA at 14 days after MCAo. Protein levels of these factors show the quantitative analysis data (a–f). The expression of
BDNF and VEGF was signiﬁcantly increased compared with the control group at 14 days after MCAo (a, b). Also, inﬂammatory cytokines
such as Cox-2, TNF-α,I L - 1 β,a n dI L - 1 α were signiﬁcantly decreased compared with the control group (c, d, e, f). Data are expressed as mean
± SD, ∗P<0.05.
proﬁle and blood circulation. Choline, a known precursor
of acetylcholine, carries an important role in cell membrane
function and signal transmission between neurons. It is
an important neurotransmitter related to storing memory
[35, 36]. These components are also known to improve
neurological deﬁcits and have neuroprotective eﬀect on
various central nervous system injury models including
transient cerebral ischemia. Although our data is limited for
detailed explanation of the mechanism of action of gongjin-
dan, these mechanisms can have neuroprotective eﬀect of
the drug. VEGF promotes angiogenesis and neurogenesis
into ischemic penumbra, where it is increased to supply
bloodinthebrain[37].Inourstudy,thegongjin-dan-treated
group demonstrated considerable expression of BDNF and
VEGF compared to the control group 14 days after MCAo.
Furthermore, TNF-α,I L - 1 β,I L - 1 α,a n dC o x - 2a r ew e l l -
studied cytokines related to inﬂammatory responses in
stroke, and both appear to exacerbate ischemic damage [38–
40]. Most of these factors were produced by microglia in the
ischemicbrainandactasdeathligandsandinitiatethedeath-
receptor signal pathway. Inhibition of these factors has been
shown to be beneﬁcial in neurological outcome and infarct
volume in stroke. In our study, there is a possibility that
thereductionininﬂammatorycytokinesbygongjin-danmay
have neuroprotective eﬀects in MCAo.
In conclusion, the result of our study suggests that
gongjin-danpromotessecretionofneurotrophicfactorssuch
as BDNF and VEGF and inhibits inﬂammatory cytokine
such as TNF-α,I L - 1 β,I L - 1 α, and Cox-2, thereby exerting its
neuroprotective eﬀect in rat MCAo model. Also, functional
recovery can be achieved as a result of increased glucose
metabolism through improved rCBF. Further studies are
needed to identify the dose-response eﬀect and the precise
mechanism of action of this novel drug.
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